What are the health needs and challenges?

Even before the emergence of COVID-19, less than half of the approximately 500,000 new cases of DR-TB each year were properly diagnosed. By collaborating with national governments, not-for-profit organizations and other members of the private sector, Johnson & Johnson is helping to support efforts to identify the “missing” people with TB who have yet to be diagnosed, and therefore treated.

Collaboration activities and how they address needs and challenges

Project inSight was a collaboration between Johnson & Johnson and the Global Fund in Indonesia that improved understanding of why it can be difficult to identify people with DR-TB. By combining the Global Fund’s scale and reach and Johnson & Johnson’s unique expertise in consumer and patient insights, new strategies can be devised to amplify efforts to identify, engage and support people diagnosed with DR-TB, particularly in the context of the COVID-19 pandemic.